Last reviewed · How we verify
NCT02282384: AVT
A Randomized Controlled Trial of Oseltamivir in Outpatients With Chronic Pulmonary Disease: a Pilot Study
Phase 4 trial testing oseltamivir in Pulmonary Disease. Withdrawn.
1 March 2015
Quick facts
| Lead sponsor | McMaster University |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Start date | 1 October 2014 |
| Primary completion | 1 March 2015 |
| Estimated completion | 1 March 2015 |
Drugs / interventions tested
- oseltamivir — full drug profile →
- Placebo
Conditions studied
- Pulmonary Disease — all drugs for Pulmonary Disease →
- Influenza — all drugs for Influenza →
Sponsor
McMaster University
Who can join
Adults 18 to 90, any sex, with Pulmonary Disease or Influenza. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
non-elective admission to hospital
Time frame: up to 28 days following randomization
A non-elective admission to hospital, in contrast to visits to the emergency department where admission does not take place. However, a prolonged stay in the emergency department (\> 24 hours) will also be considered to be hospitalization. Events that occur beyond this time period are deemed unlikely to be directly related to influenza,except functional status which will be assessed up to three mo
Sponsor's own description
The proposed pilot study will provide needed data to establish the feasibility of a conducting a large randomized controlled trial as to the effectiveness of the use of oseltamivir early in the course of influenza in outpatients with chronic pulmonary disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02282384
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of oseltamivir
Trials testing the same drug.
- NCT01258530 — A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Hea · Phase 1 · completed
- NCT00545532 — A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants. · Phase 3 · completed
Other recruiting trials for Pulmonary Disease
Currently open trials in the same condition.
- NCT07103499 — Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH) · NA · recruiting
- NCT06998550 — Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye · recruiting
- NCT04441151 — Evaluation of the Effect of Pulmonary Rehabilitation on Patients With High Flow Oxygen Therapy · NA · recruiting
- NCT07048678 — Evaluating the Impact of Preoperative Respiratory Exercises on Post-Surgical Pulmonary Outcomes RCT · NA · active not recruiting
- NCT06775106 — Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections · recruiting
Other McMaster University trials
Trials by the same sponsor.
- NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
- NCT07408128 — Partner4Exercise Randomized Controlled Trial · Phase 2, PHASE3 · not yet recruiting
- NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02282384 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McMaster University
- Last refreshed: 25 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02282384.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing